Breast Cancer

Breast Cancer

Mabel Mardones, MD

SCRI at Rocky Mountain Cancer Centers I The US Oncology Network, is a coauthor on the Late Breaking Abstract, “Giredestrant + Palbociclib vs Letrozole + PALBO as First-Line Therapy in Patients with Estrogen Receptor–Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer: Primary Analysis of the Phase III persevERA BC Trial” that will be presented on Tuesday, June 2 at 11:45 a.m. CDT during the session, Breast Cancer—Metastatic in Hall D1.  

Click here to learn more about Dr. Mardones.